Research Leadership

• John Byrd, MD
  Director; Associate Vice Chancellor for Cancer Affairs, University of Pittsburgh
• Kathryn Schmitz, PhD, MPH
  Deputy Director; Associate Director of Population Sciences
• José P. Zevallos, MD, MPH
  Deputy Director
• Chris Bakkenist, PhD
  Associate Director, Education and Training
• Kristin Bialobok, MSN, RN
  Vice President, Clinical Research
• Adam Brufsky, MD, PhD
  Co-Leader, Cancer Therapeutics Program
• Ronald Buckanovich, MD, PhD
  Co-Leader, Cancer Biology Program
• Theresa Cummings, RN, DBA, CCRP
  Associate Director, Research Administration
• Greg Delgoffe, PhD
  Associate Director, Basic Research; Director, Tumor Microenvironment Center
• Devin Dressman, PhD
  Associate Director, Research Operations and Strategic Alliances
• Charles E. Geyer, Jr, MD
  Division Chief, Malignant Hematology and Medical Oncology, UPMC Hillman Cancer Center and University of Pittsburgh
• James Herman, MD
  Co-Leader, Cancer Risk, Outcomes, and Prevention Program
• John M. Kirkwood, MD
  Director, Melanoma Disease Center
• Yana Najjar, MD
  Medical Director, Clinical and Translational Research Center
• Marci Lee Nilsen, PhD, MSN, RN, CHPN, FAAN
  Co-Leader, Cancer Risk, Outcomes, and Prevention Program
• Steffi Oesterreich, PhD
  Co-Leader, Cancer Biology Program
• Patricia Opresko, PhD
  Co-Leader, Genome Stability Program
• Roderick O’Sullivan, PhD
  Co-Leader, Genome Stability Program
• Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN
  Associate Director, Community Outreach and Engagement
• Anwaar Saeed, MD
  Co-Leader, Cancer Therapeutics Program
• Heath Skinner, MD, PhD
  Chief Medical Officer, Radiation Oncology Network; Member, Genome Stability Program
• Dario Vignali, PhD
  Co-Leader, Cancer Immunology and Immunotherapy Program
• Peter Wipf, PhD
  Co-Leader, Cancer Therapeutics Program
• Jian-Min Yuan, MD, PhD
  Co-Leader, Cancer Risk, Outcomes, and Prevention Program
• Dan Zandberg, MD
  Associate Director for Clinical Research
• Hassane Zarour, MD
  Co-Leader, Cancer Immunology and Immunotherapy Program

Visit our Research Administration section for more information.